V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210000539 | 210000539 | 1.75 | 75.3 | null | 2016-03-21 | 2016-04-09 | Cyclophosphamide+Doce+Tras Main | 02 | N | CISPLATIN + PEMETREXED | 100114973 |
| 210000549 | 210000549 | 1.64 | 71 | null | null | 2017-12-12 | Cisplatin + Pemetrexed | null | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100429937 |
| 210000550 | 210000550 | null | null | null | null | 2019-09-02 | Carboplatin + Docetaxel | null | null | TRIAL | 100667684 |
| 210000559 | 210000559 | null | null | null | null | 2019-07-27 | FEC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100917682 |
| 210000560 | 210000560 | 1.6 | 63 | null | 2020-01-05 | 2020-01-05 | FEC 60 or 75 | 02 | N | TCH | 100576379 |
| 210000572 | 210000572 | null | null | null | null | 2016-12-18 | FEC 100 | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101584546 |
| 210000578 | 210000578 | null | 71.1 | null | 2017-10-18 | 2017-10-26 | FEC + TRASTUZUMAB | 02 | N | FEC | 101730017 |
| 210000591 | 210000591 | null | null | null | 2018-08-19 | 2018-09-09 | Carboplatin + Docetaxel | null | null | DOCETAXEL | 101609229 |
| 210000604 | 210000604 | null | null | null | null | 2019-06-27 | Letrozole + Palbociclib | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100433159 |
| 210000620 | 210000620 | 1.74 | 80.2 | Palliative (P) | null | 2018-10-16 | FEC 60 or 75 | null | N | FEC + TRASTUZUMAB | 101339472 |
| 210000637 | 210000637 | 1.58 | 71.8 | null | 2018-10-02 | 2018-10-02 | Paclitaxel 7 day | N | N | DOCETAXEL | 101708171 |
| 210000644 | 210000644 | null | null | null | null | 2017-04-30 | FEC + DOCETAXEL | null | null | EC | 101583487 |
| 210000654 | 210000654 | null | null | null | null | 2018-12-15 | Cyclophosphamide + Docetaxel | 02 | N | EC | 100506077 |
| 210000660 | 210000660 | null | null | null | 2018-10-03 | 2018-10-12 | FEC 100 | N | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 101674893 |
| 210000687 | 210000687 | null | null | null | null | 2015-09-29 | CYCLOPHOSPHAMIDE + EPIRUBICIN | null | null | ROSCO TRIAL | 100998906 |
| 210000696 | 210000696 | null | null | null | 2018-09-15 | 2018-09-20 | Epirubicin (weekly) | N | N | ABEMACICLIB | 101496447 |
| 210000699 | 210000699 | null | null | null | 2019-07-18 | 2019-07-19 | Carboplatin 21day + Paclitaxel 7day | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100314676 |
| 210000707 | 210000707 | 1.44 | 71.5 | null | null | 2016-01-12 | EC | 02 | N | ABEMACICLIB + FULVESTRANT | 101476946 |
| 210000716 | 210000716 | null | null | null | null | 2017-08-02 | null | null | null | EC | 101852069 |
| 210000723 | 210000723 | null | null | null | null | 2018-09-08 | FEC + DOCETAXEL | N | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101059318 |
| 210000736 | 210000736 | null | null | null | null | 2017-06-26 | FEC 100 | null | null | TRASTUZUMAB | 101506120 |
| 210000744 | 210000744 | null | null | null | 2017-05-13 | 2017-05-28 | Cyclophosphamide + Docetaxel | 02 | null | DOCETAXEL + TRASTUZUMAB | 100491499 |
| 210000755 | 210000755 | 1.84 | 76 | null | 2016-03-17 | 2016-04-14 | FEC 100 + DOCETAXEL | null | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 101091950 |
| 210000761 | 210000761 | 1.69 | 72.2 | null | null | 2018-05-14 | FEC + DOCETAXEL | null | N | FEC + DOCETAXEL | 101652368 |
| 210000769 | 210000769 | 1.66 | 76.2 | null | 2017-10-01 | 2017-10-23 | FEC 100 | 02 | N | PACLITAXEL | 100222720 |
| 210000772 | 210000772 | null | null | null | 2019-04-24 | 2019-04-27 | CAPECITABINE + CARBOPLATIN | 2 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100251850 |
| 210000778 | 210000778 | null | null | null | null | 2018-12-13 | CARBOPLATIN + CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL | null | null | FEC + DOCETAXEL | 101102637 |
| 210000800 | 210000800 | null | null | null | null | 2017-06-27 | Paclitaxel 7 day | null | null | FEC | 101444693 |
| 210000808 | 210000808 | 1.65 | 82.6 | null | 2016-07-20 | 2016-08-04 | Trial Unspecified | 02 | N | EC | 101213199 |
| 210000821 | 210000821 | 1.6 | 64 | null | 2018-06-17 | 2018-07-05 | FEC 100 | 02 | N | FEC + DOCETAXEL | 100577520 |
| 210000837 | 210000837 | 1.65 | 76 | null | 2018-05-16 | 2018-05-28 | FEC 100 + DOCETAXEL | 02 | N | FEC | 100598247 |
| 210000838 | 210000838 | null | null | null | null | 2018-03-24 | Carboplatin AUC 6 - 10 | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100329010 |
| 210000867 | 210000867 | null | null | Curative (C) | 2018-12-19 | 2019-01-16 | EC | 02 | N | TRASTUZUMAB | 101456012 |
| 210000880 | 210000880 | 1.6 | 76 | null | null | 2019-08-31 | null | null | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100234295 |
| 210000882 | 210000882 | null | null | null | 2018-11-06 | 2018-11-08 | EC | 02 | N | EC | 100438675 |
| 210000912 | 210000912 | null | null | null | null | 2018-11-18 | EC | null | null | CARBOPLATIN + CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL | 101579585 |
| 210000948 | 210000948 | 1.72 | 63.6 | null | 2018-11-17 | 2018-11-18 | ROSCO Trial | N | null | EC | 101266635 |
| 210000956 | 210000956 | 1.79 | 63 | null | 2018-09-29 | 2018-10-12 | FEC + TRASTUZUMAB | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101481978 |
| 210000959 | 210000959 | 1.72 | 61 | null | 2018-05-13 | 2018-05-13 | FEC 100 + DOCETAXEL | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100437903 |
| 210000965 | 210000965 | null | null | null | null | 2017-02-17 | FEC 60 or 75 | null | null | EC | 101293097 |
| 210000982 | 210000982 | null | null | null | 2019-02-15 | 2019-02-21 | FEC | null | N | DOCETAXEL | 101384637 |
| 210001002 | 210001002 | null | null | null | 2018-07-16 | 2018-07-18 | FEC 60 or 75 | 02 | N | CARBOPLATIN + CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL | 101001965 |
| 210001035 | 210001035 | null | null | null | null | 2019-01-01 | FEC + TRASTUZUMAB | N | N | EC | 101218839 |
| 210001036 | 210001036 | null | null | null | null | 2017-09-14 | FEC 100 | null | null | EC | 100130408 |
| 210001037 | 210001037 | null | null | null | 2018-12-28 | 2019-01-10 | FEC 100 | 01 | N | PACLITAXEL | 100635580 |
| 210001041 | 210001041 | null | null | null | 2018-07-08 | 2018-07-10 | FEC 100 | N | N | FEC + DOCETAXEL | 100697620 |
| 210001055 | 210001055 | null | null | null | null | 2019-11-17 | null | null | null | FEC | 100928175 |
| 210001075 | 210001075 | null | null | null | null | 2018-12-30 | Trial Unspecified | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 100009254 |
| 210001102 | 210001102 | null | null | Neo-adjuvant (N) | null | 2019-01-06 | EC | null | null | CARBOPLATIN + PACLITAXEL | 101015160 |
| 210001103 | 210001103 | null | null | null | null | 2016-05-05 | FEC + DOCETAXEL | 01 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101374319 |